Abstract

Summary

This paper proposes targeting sleep and circadian rhythms as a novel therapeutic strategy for Parkinson's disease, with light exposure via ipRGC pathways serving as a potential non-pharmacological intervention. Lighting designers and healthcare providers in neurology and elder care settings should consider circadian-supportive lighting environments to complement treatment for Parkinson's patients.
Abstract

Key Findings

  • Identifies melanopsin-containing ipRGCs as a third class of retinal photoreceptors critical to circadian entrainment, with implications for light-based therapies in Parkinson's disease.
  • Proposes that sleep and circadian system dysfunction in Parkinson's disease represents a targetable pathway, suggesting chronotherapeutic and light therapy approaches as adjunct treatments.
Categories

Categories

Dementia & Elder Care: Explores sleep and circadian system as treatment targets in Parkinson's disease, a neurodegenerative condition common in elder care.
Sleep & Circadian Health: Addresses circadian disruption and sleep dysfunction as key factors in Parkinson's disease progression and potential therapeutic intervention.
The Science of Light: Highlights the role of melanopsin-containing ipRGCs in circadian photoreception relevant to non-pharmacological light-based treatments.
Authors

Author(s)

B Feigl, SJG Lewis, O Rawashdeh
Publication Date

Publication Year

2023
View more publications